Biomaterial drug delivery and surface modification compositions

Details Biomaterial drug delivery and surface modification compositions Biomaterial drug delivery and surface modification compositions

2005-12-01

2010-12-14

Hartley, Michael G (Department: 1618)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Reexamination Certificate

active

07850982

ABSTRACT:
Compositions are provided which include a polymer made at least in part from a polyoxyalkylene copolymer, such as a poloxamer. The polymer may be combined with a second component to form a blend or emulsion. The resulting composition may be utilized to form medical devices, drug delivery devices, or coatings for other medical devices.

REFERENCES:
patent: 4047533 (1977-09-01), Perciaccante et al.
patent: 4954593 (1990-09-01), Vara et al.
patent: 5330768 (1994-07-01), Park et al.
patent: 5352515 (1994-10-01), Jarrett et al.
patent: 5442016 (1995-08-01), Jarrett et al.
patent: 5530074 (1996-06-01), Jarrett et al.
patent: 5621050 (1997-04-01), Jarrett et al.
patent: 5716376 (1998-02-01), Roby et al.
patent: 5780044 (1998-07-01), Yewey et al.
patent: 6143037 (2000-11-01), Goldstein et al.
patent: 6177094 (2001-01-01), Jiang
patent: 6228954 (2001-05-01), Kaplan et al.
patent: 6653423 (2003-11-01), Yamamoto et al.
patent: 6706260 (2004-03-01), Tanaka et al.
patent: 6805876 (2004-10-01), Leong et al.
patent: 6991804 (2006-01-01), Helmus et al.
patent: 2003/0022242 (2003-01-01), Anderson
patent: 2003/0157193 (2003-08-01), McDonald et al.
patent: 2005/0175667 (2005-08-01), Carlyle
patent: 2006/0193884 (2006-08-01), Stopek et al.
patent: 2007/0032666 (2007-02-01), Read et al.
patent: 2008/0033106 (2008-02-01), Koroskenyi et al.
patent: 0 562 612 (1993-09-01), None
patent: 055 8965 (1993-09-01), None
patent: 0 752 245 (1997-01-01), None
patent: WO 2007/133782 (2007-11-01), None
Li et al, Morphology and Levonorgestrel Release Behavior of Polycaprolactone/Poly(ethylene oxide)/Polylactide Tri-component Copolymeric Microspheres, Polymers for Advanced Technologies, 2003, 14, 239-244.
Ha J C et al: “Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (Pluronic)/poly(sigma-caprolactone) (PCL) amphiphilic block copolymeric nanospheres-I Preperation and characterization” Journal of Controlled Release, Elsevier, Amsterdam, NL, vol. 62, No. 3, Dec. 6, 1999.
International Search Report from Application No. PCT/US07/26003 dated Apr. 16, 2008.
Iwasaki et al., “In vitro and ex vivo blood compatibility study of 2-methacryloyloxyethyl phosphorylcholine (MPC) copolymer-coated hemodialysis hollow fibers”,Journal of Artificial Organs(2003), 6(4):260-266.
Nakabayashi et al., “Copolymers of 2-methacryloyloxyethyl phosphorylcholine (MPC) as biomaterials”,Bio-Medical Materials and Engineering(2004), vol. 14, 345-354.

Affiliated with

Also associated with

Rating

Biomaterial drug delivery and surface modification compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomaterial drug delivery and surface modification compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomaterial drug delivery and surface modification compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4202121